Arjo will issue its interim report for Q2 2023 on Friday July 14 at 07:00 CEST, followed by a conference call at 08:00 CEST, hosted by Joacim Lindoff, President & CEO.

Fund managers, analysts and media are invited to participate in a conference call and presentation of the report via the following link: https://ir.financialhearings.com/arjo-q2-2023

Those who wish to ask questions verbally via the teleconference will need to register via the link below. A phone number and a conference ID will be provided after registration in order to access the conference. Link to registration:

https://conference.financialhearings.com/teleconference/?id=200819

Alternatively, use the following link to download the presentation:
https://www.arjo.com/int/about-us/investors/reports--presentations/2023/

Agenda

07:45              Call in to the conference
08:00              Review of the interim report
08.30              Q&A
09.00              End of conference

A recorded version of the conference is accessible for three years via the following link:
https://ir.financialhearings.com/arjo-q2-2023

For more information, please contact:                                                                                              

Maria Nilsson, EVP Communication & Public Relations
Tel: +46 734 244 515
Email: maria.nilsson@arjo.com  

Sara Ehinger, VP Investor Relations & Corporate Communications
Tel: +46 723 597 794
Email: sara.ehinger@arjo.com

About Arjo

At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With 6,800 people worldwide and 65 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com